Advertisement

Percutaneous Sclerotherapy of Superficial Vascular Malformation Leading to Bleomycin Induced Lung Injury and Lipoid Pneumonia

  • Daisy Khera
  • Ambar Bhatnagar
  • Pushpinder S. Khera
  • Prawin Kumar
Scientific Letter
  • 15 Downloads

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    Spence J, Krings T, TerBrugge KG, Da Costa LB, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. Am J Neuroradiol. 2010;31:955–60.CrossRefPubMedGoogle Scholar
  2. 2.
    Atwa K, Abuhasna S, Shihab Z, Hashaykeh N, Hasan R. Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation. Pediatr Pulmonol. 2010;45:192–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Méndez-Echevarría A, Fernandez-Prieto A, de la Serna O, et al. Acute lung toxicity after intralesional bleomycin sclerotherapy. Pediatrics. 2018;141:pii: e20161787.Google Scholar
  4. 4.
    Rabe E, Breu FX, Cavezzi A, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29:338–54.CrossRefPubMedGoogle Scholar
  5. 5.
    Hatamaru K, Azuma S, Akamatsu T, et al. Pulmonary embolism after arterial chemoembolization for hepatocellular carcinoma: an autopsy case report. World J Gastroenterol. 2015;21:1344–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  • Daisy Khera
    • 1
  • Ambar Bhatnagar
    • 1
  • Pushpinder S. Khera
    • 2
  • Prawin Kumar
    • 1
  1. 1.Department of PediatricsAll India Institute of Medical SciencesJodhpurIndia
  2. 2.Department of RadiologyAll India Institute of Medical SciencesJodhpurIndia

Personalised recommendations